PROUROCARE MEDICAL INC.: 10-Q/A filed 2011-08-17

Name: PROUROCARE MEDICAL INC.: 10-Q/A filed 2011-08-17
Creator: PROUROCARE MEDICAL INC.

What PROUROCARE MEDICAL INC. reported in its quarterly report amendment filed 2011-08-17 (fiscal Q2 2011): 23 published measures, 73 facts as tagged in accession 0001144204-11-048182.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-Q/A (quarterly report amendment)
Filed: 2011-08-17
Fiscal period: fiscal Q2 2011
Accession: 0001144204-11-048182 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PROUROCARE MEDICAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-06-30	416,276	USD
At 2010-12-31	575,205	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2011-06-30	2,318,026	USD
At 2010-12-31	2,201,522	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-06-30	-1,901,750	USD
At 2010-12-31	-1,626,317	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-08-08	1,000,874	USD
At 2011-06-30	35,248	USD
At 2010-12-31	419,136	USD
At 2010-06-30	771,016	USD
At 2009-12-31	1,000,874	USD
At 1999-08-16	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-488,813	USD	91
2011-01-01 to 2011-06-30	-1,003,761	USD	181
1999-08-17 to 2011-06-30	-34,903,018	USD	4336
2010-04-01 to 2010-06-30	-1,396,281	USD	91
2010-01-01 to 2010-06-30	-2,967,972	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	-583,485	USD	181
1999-08-17 to 2011-06-30	-14,211,795	USD	4336
2010-01-01 to 2010-06-30	-1,383,455	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	0	USD	181
1999-08-17 to 2011-06-30	36,767	USD	4336
2010-01-01 to 2010-06-30	14,314	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	199,597	USD	181
1999-08-17 to 2011-06-30	14,283,810	USD	4336
2010-01-01 to 2010-06-30	1,167,911	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	0	USD	181
1999-08-17 to 2011-06-30	-36,767	USD	4336
2010-01-01 to 2010-06-30	-14,314	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-06-30	-34,903,018	USD
At 2010-12-31	-33,899,257	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-06-30	14,956	USD
At 2010-12-31	15,232	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	69,395	USD	181
1999-08-17 to 2011-06-30	2,607,741	USD	4336
2010-01-01 to 2010-06-30	62,903	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	-377,134	USD	91
2011-01-01 to 2011-06-30	-726,342	USD	181
1999-08-17 to 2011-06-30	-22,076,549	USD	4336
2010-04-01 to 2010-06-30	-529,159	USD	91
2010-01-01 to 2010-06-30	-1,098,463	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-06-30	315,315	USD
At 2010-12-31	555,573	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-06-30	1,816,310	USD
At 2010-12-31	1,725,479	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-06-30	564,864	USD
At 2010-12-31	614,234	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	0	USD	181
1999-08-17 to 2011-06-30	100,000	USD	4336
2010-01-01 to 2010-06-30	0	USD	181

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	377,134	USD	91
2011-01-01 to 2011-06-30	726,342	USD	181
1999-08-17 to 2011-06-30	22,076,549	USD	4336
2010-04-01 to 2010-06-30	529,159	USD	91
2010-01-01 to 2010-06-30	1,098,463	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	33,128	USD	91
2011-01-01 to 2011-06-30	61,820	USD	181
1999-08-17 to 2011-06-30	7,992,115	USD	4336
2010-04-01 to 2010-06-30	74,932	USD	91
2010-01-01 to 2010-06-30	159,086	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-06-30	16,238,526	shares
At 2010-12-31	15,777,883	shares

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2011-04-01 to 2011-06-30	344,006	USD	91
2011-01-01 to 2011-06-30	664,522	USD	181
1999-08-17 to 2011-06-30	14,084,434	USD	4336
2010-04-01 to 2010-06-30	454,227	USD	91
2010-01-01 to 2010-06-30	939,377	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	0	USD	181
1999-08-17 to 2011-06-30	9,030,756	USD	4336
2010-01-01 to 2010-06-30	0	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2011-01-01 to 2011-06-30	130,536	USD	181
1999-08-17 to 2011-06-30	775,174	USD	4336
2010-01-01 to 2010-06-30	-205,595	USD	181

Inspect the source

Entity: PROUROCARE MEDICAL INC. / CIK 0001222244
Captured: 2026-09-23 02:44 UTC
SEC response SHA-256: 6f6483d08fb0338d649d04fa2645adb0bc4d7d6c0b26697239b8fb6c0e8a7e0c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001222244.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))